Prostanoid receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on Prostanoid Receptors [701]) are activated by the endogenous ligands prostaglandins PGD2, PGE1, PGE2 , PGF2α, PGH2, prostacyclin [PGI2] and thromboxane A2. Differences and similarities between human and rodent prostanoid receptor orthologues, and their specific roles in pathophysiologic conditions are reviewed in [452]. Measurement of the potency of PGI2 and thromboxane A2 is hampered by their instability in physiological salt solution; they are often replaced by cicaprost and U46619, respectively, in receptor characterization studies.
CITATION STYLE
Clapp, L., Giembycz, M., Heinemann, A., Jones, R. L., Narumiya, S., Norel, X., … Yao, C. (2023). Prostanoid receptors in GtoPdb v.2023.1. IUPHAR/BPS Guide to Pharmacology CITE, 2023(1). https://doi.org/10.2218/gtopdb/f58/2023.1
Mendeley helps you to discover research relevant for your work.